X hits on this document

Powerpoint document

Clevidipine Phase III Studies: Perioperative Hypertension - page 19 / 65

217 views

0 shares

0 downloads

0 comments

19 / 65

Patient Disposition

Clevidipine

NTG

Clevidipine

SNP

Clevidipine

NIC

Patients randomized

312

316

363

376

296

301

Patients meeting post-randomization criteria (mITT)

270

278

297

284

188

195

Patients not receiving study medication a

2

0

1

1

1

1

Patients who received study medication (safety population)

268

278

296

283

188

193

Total Safety Population

546

579

381

Aronson S et al. Anesth Analg 2008 (in press)

a Two patients in the CLV/NIC group did not receive study medication and were excluded from the safety population. In addition, one patient in the same treatment was randomized to NIC but received CLV instead. This patient was excluded from the NIC safety population and included in the CLV safety population

Document info
Document views217
Page views217
Page last viewedSun Dec 11 04:44:55 UTC 2016
Pages65
Paragraphs1351
Words4734

Comments